India, April 30 -- image credit- shutterstock
India has emerged as a key player in the global biopharmaceutical industry, and with the rapid expansion of biologics and biosimilars, the role of domestic biosuppliers has never been more crucial. Also, with a funding support of Rs 1500 crore under the Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme by the government, for promoting high performance biomanufacturing and biofoundry support to the industry, the call for reducing the dependence on imported research equipment, consumables and raw materials is getting strongly established.
According to the India Bioeconomy Report 2025, developed by the Association of Biotechnology Led Enterprises (ABLE), the b...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.